New drug formulations of colony-stimulating factors in oncohematology
The use of colony-stimulating factors became an autonomous approach in complex supportive care of blood tumors. By indications of granulocyte colony-stimulating factor (G-CSF) it is possible to reduce of neutropenic period, perform an optimal timing of therapy, decrease a number of infection complic...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-03-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849409243323564032 |
|---|---|
| author | T. T. Valiev R. R. Fatkhullin Yu. E. Ryabukhina P. A. Zeynalova |
| author_facet | T. T. Valiev R. R. Fatkhullin Yu. E. Ryabukhina P. A. Zeynalova |
| author_sort | T. T. Valiev |
| collection | DOAJ |
| description | The use of colony-stimulating factors became an autonomous approach in complex supportive care of blood tumors. By indications of granulocyte colony-stimulating factor (G-CSF) it is possible to reduce of neutropenic period, perform an optimal timing of therapy, decrease a number of infection complications. The development and active use of a new G-CSF drug formulation – pegfilgrastim do not decrease the duration of neutropenic period significantly, but reduced the frequency of drug administration, period of hospitalization and a probability of “ineffective” hematopoietic stem cell mobilization.In the current issue it is presented the results of modern studies, which demonstrate advantages of PEG-G-CSF in contrast to G-CSF, algorithm for febrile neutropenia risk assessment, the questions for G-CSF administrations in patients with blood tumors. |
| format | Article |
| id | doaj-art-e3f3c1ddbf4f4887af275b2e59f8b908 |
| institution | Kabale University |
| issn | 1818-8346 2413-4023 |
| language | Russian |
| publishDate | 2023-03-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Онкогематология |
| spelling | doaj-art-e3f3c1ddbf4f4887af275b2e59f8b9082025-08-20T03:35:33ZrusABV-pressОнкогематология1818-83462413-40232023-03-0118112613110.17650/1818-8346-2023-18-1-126-131677New drug formulations of colony-stimulating factors in oncohematologyT. T. Valiev0R. R. Fatkhullin1Yu. E. Ryabukhina2P. A. Zeynalova3N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaClinical Hospital “Lapino” of the “Mother and Child” Group of companiesI.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Clinical Hospital “Lapino” of the “Mother and Child” Group of companiesThe use of colony-stimulating factors became an autonomous approach in complex supportive care of blood tumors. By indications of granulocyte colony-stimulating factor (G-CSF) it is possible to reduce of neutropenic period, perform an optimal timing of therapy, decrease a number of infection complications. The development and active use of a new G-CSF drug formulation – pegfilgrastim do not decrease the duration of neutropenic period significantly, but reduced the frequency of drug administration, period of hospitalization and a probability of “ineffective” hematopoietic stem cell mobilization.In the current issue it is presented the results of modern studies, which demonstrate advantages of PEG-G-CSF in contrast to G-CSF, algorithm for febrile neutropenia risk assessment, the questions for G-CSF administrations in patients with blood tumors.https://oncohematology.abvpress.ru/ongm/article/view/805leukemialymphomasupportive carecolony-stimulating factorpegfilgrastim |
| spellingShingle | T. T. Valiev R. R. Fatkhullin Yu. E. Ryabukhina P. A. Zeynalova New drug formulations of colony-stimulating factors in oncohematology Онкогематология leukemia lymphoma supportive care colony-stimulating factor pegfilgrastim |
| title | New drug formulations of colony-stimulating factors in oncohematology |
| title_full | New drug formulations of colony-stimulating factors in oncohematology |
| title_fullStr | New drug formulations of colony-stimulating factors in oncohematology |
| title_full_unstemmed | New drug formulations of colony-stimulating factors in oncohematology |
| title_short | New drug formulations of colony-stimulating factors in oncohematology |
| title_sort | new drug formulations of colony stimulating factors in oncohematology |
| topic | leukemia lymphoma supportive care colony-stimulating factor pegfilgrastim |
| url | https://oncohematology.abvpress.ru/ongm/article/view/805 |
| work_keys_str_mv | AT ttvaliev newdrugformulationsofcolonystimulatingfactorsinoncohematology AT rrfatkhullin newdrugformulationsofcolonystimulatingfactorsinoncohematology AT yueryabukhina newdrugformulationsofcolonystimulatingfactorsinoncohematology AT pazeynalova newdrugformulationsofcolonystimulatingfactorsinoncohematology |